Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-07 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +75,409 $9.53 $719K 106,511
2017-11-07 Doberstein Stephen K SVP & Chief Scientific Officer Sale −75,409 $25.78 $1.9M 31,102
2017-11-07 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −75,409 300,000
2017-11-06 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +5,117 $10.69 $55K 63,350
2017-11-06 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −5,117 $25.07 $128K 58,233
2017-11-06 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −5,117 17,300
2017-11-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +20,914 $9.53 $199K 52,016
2017-11-06 Doberstein Stephen K SVP & Chief Scientific Officer Sale −20,914 $24.98 $522K 31,102
2017-11-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −20,914 375,409
2017-11-01 ROBIN HOWARD W President & CEO Exercise or conversion +83,334 $11.34 $945K 235,838
2017-11-01 ROBIN HOWARD W President & CEO Sale −83,334 $23.57 $2.0M 152,504
2017-11-01 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −83,334 166,666
2017-10-09 ROBIN HOWARD W President & CEO Exercise or conversion +83,333 $11.34 $945K 235,837
2017-10-09 ROBIN HOWARD W President & CEO Sale −83,333 $24.20 $2.0M 152,504
2017-10-09 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −83,333 250,000
2017-10-05 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +7,583 $10.69 $81K 65,816
2017-10-05 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −7,583 $25.00 $190K 58,233
2017-10-05 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −7,583 22,417
2017-10-05 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +43,677 $9.53 $416K 74,779
2017-10-05 Doberstein Stephen K SVP & Chief Scientific Officer Sale −43,677 $24.97 $1.1M 31,102

Page 39 of 43 · 847 trades